TSMC is mulling upgrading the capabilities of its yet-to-be-built Fab 23 phase 2 in Japan in a bid to make chips on its N4 process technology (4nm-class) there, according to Nikkei. Advancing fab ...
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, announces that it is among a group of innovative UK ...
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, announces that it is among a group of innovative UK ...